Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Endocrinology

• Publication date

  2011-07-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1210/en.2011-0170PMID 21771887PMCID PMC3159783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.

  2011cited by this paper
• Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity.

  2010cited by this paper
• Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice

  2010cited by this paper
• Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily

  2010cited by this paper
• Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.

  2010cited by this paper
• Role of full-length osteoprotegerin in tumor cell biology

  2009cited by this paper
• Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.

  2009cited by this paper
• RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats

  2008cited by this paper
• Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function

  2008cited by this paper
• Perspective: Quantifying Osteoblast and Osteocyte Apoptosis: Challenges and Rewards

  2007cited by this paper
• Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids*

  2007cited by this paper
• Glucocorticoids suppress bone formation via the osteoclast.

  2006cited by this paper
• Bone quality--the material and structural basis of bone strength and fragility.

  2006cited by this paper
• Hydraulic Strengthening Affects the Stiffness and Strength of Cortical Bone

  2005cited by this paper
• Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.

  2004cited by this paper
• The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.

  2004cited by this paper
• The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival.

  2004cited by this paper
• Whither flows the fluid in bone?" An osteocyte's perspective.

  2003cited by this paper
• Proteasomal Degradation of Runx2 Shortens Parathyroid Hormone-induced Anti-apoptotic Signaling in Osteoblasts

  2003cited by this paper
• "Whither flows the fluid in bone?" An osteocyte's perspective.

  2003cited by this paper
• The Role of Interstitial Fluid Flow in the Remodeling Response to Fatigue Loading

  2002cited by this paper
• Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.

  2002cited by this paper
• Osteoprotegerin: a link between osteoporosis and arterial calcification?

  2001cited by this paper
• Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells*

  2000cited by this paper
• Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo

  2000cited by this paper
• Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells.

  2000cited by this paper
• Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.

  1999cited by this paper
• Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

  1999cited by this paper
• Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1.

  1999cited by this paper
• Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

  1998cited by this paper
• Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex.

  1996cited by this paper
• The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932.

  1994cited by this paper
• PATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS

  1989cited by this paper
• Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

  1987cited by this paper
• Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

  1987cited by this paper
• Changes in the red cell, plasma and inulin spaces and in the total water contents of rat femurs in cortisone induced osteoporosis

  1978cited by this paper
• The Fire of Life: An Introduction to Animal Energetics

  1975cited by this paper

• Therapeutic Management of Glucocorticoid-Induced Osteoporosis with a Focus on Older Adults: A Narrative Review

  2025cites this paper
• Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

  2025cites this paper
• Protein kinase G2 activation restores Wnt signaling and bone mass in glucocorticoid-induced osteoporosis in mice

  2024cites this paper
• Fluid shear stress-mediated Piezo1 alleviates osteocyte apoptosis by activating the PI3K/Akt pathway.

  2024cites this paper
• Pathogenic mechanisms of glucocorticoid-induced osteoporosis.

  2023cites this paper
• Identification of an intronic enhancer regulating RANKL expression in osteocytic cells

  2023cites this paper
• Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes

  2022influential citation
• Novel in vitro microfluidic platform for osteocyte mechanotransduction studies.

  2021cites this paper
• Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice

  2021cites this paper
• Sparse dose-dependent difference in skeletal effects of short-term glucocorticoid excess in outbred Swiss mice

  2021cites this paper
• Animal Model for Glucocorticoid Induced Osteoporosis: A Systematic Review from 2011 to 2021

  2021cites this paper
• Elevation of the unfolded protein response increases RANKL expression

  2020cites this paper
• Glucocorticoid Regulation of Osteoclasts

  2020cites this paper
• Bone Strength/Bone Mass Discrepancy in Glucocorticoid‐Treated Adult Mice

  2020cites this paper
• WISP-2 expression induced by Teriparatide treatment affects in vitro osteoblast differentiation and improves in vivo osteogenesis.

  2020cites this paper
• University of Birmingham Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy

  2018cites this paper
• Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy.

  2018cites this paper
• Prevention of glucocorticoid morbidity in giant cell arteritis

  2018cites this paper
• Animal models to explore the effects of glucocorticoids on skeletal growth and structure.

  2018cites this paper
• The Pathophysiological Sequence of Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Male Mice

  2017cites this paper
• Mechanical instability and titanium particles induce similar transcriptomic changes in a rat model for periprosthetic osteolysis and aseptic loosening

  2017cites this paper
• Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis

  2017cites this paper
• An evaluation of the effect of pulsed wave low-level laser therapy on the biomechanical properties of the vertebral body in two experimental osteoporosis rat models

  2016cites this paper
• Anti-osteoporotic activity of the ethanol extracts of eucommia ulmoides in glucocorticoid-induced osteoporosis male rats through the activation of androgen receptor signaling

  2016cites this paper
• Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice

  2016cites this paper
• Supraphysiologic glucocorticoid administration increased biomechanical bone strength of rats' vertebral body

  2015influential citation
• Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone

  2015cites this paper
• Loss of milk fat globule-epidermal growth factor 8 (MFG-E8) in mice leads to low bone mass and accelerates ovariectomy-associated bone loss by increasing osteoclastogenesis.

  2015cites this paper
• Glucocorticoid-induced osteoporosis: who to treat with what agent?

  2015cites this paper
• Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone.

  2015cites this paper
• Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia.

  2015cites this paper
• Cerebral ischemia increases bone marrow CD4+CD25+FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system.

  2015cites this paper
• Differences in osteogenic and apoptotic genes between osteoporotic and osteoarthritic patients

  2013cites this paper
• Osteocytes: Master Orchestrators of Bone

  2013cites this paper
• Acute Effects of Glucocorticoids on Serum Markers of Osteoclasts, Osteoblasts, and Osteocytes

  2013cites this paper
• Osteocyte apoptosis.

  2013cites this paper
• Osteoblast migration into type I collagen gel and differentiation to osteocyte-like cells within a self-produced mineralized matrix: a novel system for analyzing differentiation from osteoblast to osteocyte.

  2013cites this paper
• AUTOPHAGY IN SKELETAL HOMEOSTASIS : ROLE IN THE OSTEOBLAST LINEAGE UNDER PHYSIOLOGICAL AND STRESS CONDITION

  2013cites this paper
• The osteocyte: an endocrine cell ... and more.

  2013cites this paper
• Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.

  2012cites this paper
• Glucocorticoid-induced osteoporosis and osteonecrosis.

  2012cites this paper
• Osteocyte regulation of bone mineral: a little give and take

  2012cites this paper
• Glucocorticoid-induced osteonecrosis

  2012cites this paper
• Computer simulation of the osteocyte and bone lining cell network and the effect of normal physiological changes in cellular functions on that network

  2012cites this paper
• Management of Glucocorticoid-Induced Osteoporosis

  2012cites this paper
• Glucocorticoid induced osteoporosis

  2010cites this paper